Inhibrx Biosciences (INBX) Other Non Operating Income (2023 - 2025)
Historic Other Non Operating Income for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to -$46000.0.
- Inhibrx Biosciences' Other Non Operating Income fell 21219.51% to -$46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282000.0, marking a year-over-year decrease of 9720.28%. This contributed to the annual value of $75000.0 for FY2024, which is 11293.1% up from last year.
- Per Inhibrx Biosciences' latest filing, its Other Non Operating Income stood at -$46000.0 for Q3 2025, which was down 21219.51% from -$246000.0 recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Other Non Operating Income registered a high of $60000.0 during Q4 2024, and its lowest value of -$246000.0 during Q2 2025.
- In the last 3 years, Inhibrx Biosciences' Other Non Operating Income had a median value of -$54500.0 in 2024 and averaged -$77700.0.
- Per our database at Business Quant, Inhibrx Biosciences' Other Non Operating Income surged by 13797.47% in 2024 and then crashed by 84545.45% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Other Non Operating Income (Quarter) stood at -$158000.0 in 2023, then skyrocketed by 137.97% to $60000.0 in 2024, then plummeted by 176.67% to -$46000.0 in 2025.
- Its Other Non Operating Income stands at -$46000.0 for Q3 2025, versus -$246000.0 for Q2 2025 and -$50000.0 for Q1 2025.